Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 472576017 | Tauroselcholic acid[75Se] 370kBq capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 726907013 | Tauroselcholic acid[75Se] 370kBq capsule (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1194680015 | Tauroselcholic acid[75Se] 370kBq capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3471677010 | Tauroselcholic acid[75Se] 370 kBq/1 each oral capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3471678017 | Product containing tauroselcholic acid[75Se] 370 kBq/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3485061013 | Product containing tauroselcholic acid[75Se] 370 kBq/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3567507017 | Product containing only tauroselcholic acid[75Se] 370 kBq/1 each oral capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3567508010 | Product containing only tauroselcholic acid[75Se] 370 kBq/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3683283011 | Tauroselcholic acid (75-Se) 370 kBq oral capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3683284017 | Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3683285016 | Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 108278301000001116 | Tauroselcholic acid[75Se] 370 kBq/1 each oral capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Is a | Product containing selenium-75 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has active ingredient | Tauroselcholic (Selenium-75 [Se-75]) acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has active ingredient | Selenium radioisotope | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has active ingredient | Selenium-75 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has active ingredient | Tauroselcholic (Selenium-75 [Se-75]) acid | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has basis of strength substance | Tauroselcholic (Selenium-75 [Se-75]) acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has presentation strength numerator value | 370 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has presentation strength numerator unit | Kilobecquerel | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has precise active ingredient | Tauroselcholic (Selenium-75 [Se-75]) acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Is a | Product containing selenium-75 in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Is a | Product containing only selenium-75 in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tauroselcholic acid[75Se] 370kBq capsule - product | Is a | False | Product containing precisely tauroselcholic acid (75-Se) 370 kilobecquerel/1 each conventional release oral capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR